Simultaneous online SPE-LC-MS/MS quantification of six widely used synthetic progestins in human plasma

Analytical and Bioanalytical Chemistry

Volumn 403, Issue 4, 2012, Pages 961-972

  Moser, Christina ^a   Zoderer, Daniela ^a   Luef, Gerhard ^b   Rauchenzauner, Markus ^c,d   Wildt, Ludwig ^d   Griesmacher, Andrea ^a   Seger, Christoph ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c Saint Vincent Hospital Zams   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antiepileptics; Drug monitoring; LC MS MS; Progestins; SRM

Indexed keywords

ANTIEPILEPTICS; DRUG MONITORING; LC-MS/MS; PROGESTINS; SRM;

CHEMICAL ANALYSIS; DRUG INTERACTIONS; EXPERIMENTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPES; MASS SPECTROMETRY; PATIENT MONITORING; PLASMA (HUMAN);

PLASMAS;

ANTICONVULSIVE AGENT; CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

BLOOD; CONFERENCE PAPER; DRUG MONITORING; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTRACEPTIVE AGENTS, FEMALE; DRUG MONITORING; HUMANS; PROGESTERONE CONGENERS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84861234658     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5612-0     Document Type: Conference Paper

References (53)

1. Granfors MT, Backman JT, Laitila J, Neuvonen PJ (2005) Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Clin Parmacol Ther 78:400-411
2. Back DJ, Orme ML (1990) Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokin 18:472-484 (Pubitemid 20183889)
3. Barditch-Crovo P, Braun Trapnell C, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C (1999) The effects of rifampin and rifubatin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 65:428-438 (Pubitemid 29196547)
4. Dickinson BD, Altman RD, Nielsen NH, Sterling ML (2001) Drug interactions between oral contraceptives and antibiotics. Obst Gyn 98:853-860 (Pubitemid 33042558)
5. Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL (2005) Mechanism-based inhibition of cytochrome P4503A4 by therapeutic drugs. Clin Pharmacokinet 44:279-304 (Pubitemid 40477790)
6. Palovaara S, Kivistö KT, Tapanainen P, Manninen P, Neuvonen PJ, Laine K (2000) Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity measured by midazolam 1'-hydroxylation. Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity measured by midazolam 1'-hydroxylation. Br J Clin Pharmacol 50:333-337
7. Wilbur K, Ensom MHH (2000) Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants. Clin Pharmacokin 38:355-365 (Pubitemid 30229471)
8. Sidhu J, Job S, Singh S, Philipson R (2006) The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 61:191-199
9. Patsalos PN, Perucca E (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2:473-481 (Pubitemid 36876104)
10. Sabers A, Ohman I, Christensen J, Tomson T (2003) Oral contraceptives reduce lamotrigine plasma levels. Neurology 61:570-571 (Pubitemid 37025386)
11. Berzas JJ, Rodriguez J, Castaneda G (1997) Simultaneous determination of ethinylestradiol and levonorgestrel in oral contraceptives by derivative spectrophotometry. Analyst 122:41-44 (Pubitemid 27064911)
12. Nevado JJB, Flores JR, Penalvo GC (1997) Simultaneous spectrophotometric determination of ethinylestradiol and levonorgestrel by partial least squares and principal component regression multivariate calibration. Simultaneous spectrophotometric determination of ethinylestradiol and levonorgestrel by partial least squares and principal component regression multivariate calibration. Anal Chim Acta 340:257-265
13. Bebawy LI, Mostafa AA, Refaat HH (2001) Different methods for the determination of gestodene, and cyproterone acetate in raw material and dosage form. J Pharm Biomed Anal 25:425-436 (Pubitemid 32493899)
14. Berzas NJJ, Rodriguez FJ, Castaneda P, Guzmán B (1997) Simultaneous determination of ethinylestradiol by derivative spectrophotometry. Anal Lett 30:2221-2233 (Pubitemid 27492884)
15. Berzas NJJ, Rodriguez FJ, Castaneda P (1999) Voltammetric behaviour of gestodene using square-wave technique. Determination in oral contraceptives. Electroanal 11:268-273
16. El-Enany N, El-Sherbiny D, Belal F (2010) Voltammetric determination of cyproterone acetate in pharmaceutical preparartions. Int J Biomed Sci 6:128-134
17. Markopoulou CK, Koundourellis JE (2006) Development of a validated liquid chromatography method for the simultaneous determination of ethinyl estradiol, cyproterone acetate, and norgestrel in breast milk following solid-phase extraction. Development of a validated liquid chromatography method for the simultaneous determination of ethinyl estradiol, cyproterone acetate, and norgestrel in breast milk following solid-phase extraction. J Liq Chromatogr Rel Tech 29:685-700
18. Henry de Hassonville S, Chiap P, Liégeois JF, Evrard B, Delattre L, Crommen J, Piel G, Hubert P (2004) Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. J Pharm Biomed Anal 36:133-143
19. Christiaens B, Chiap P, Rbeida O, Cello D, Crommen J, Hubert P (2003) Fully automated method for the liquid chromatographic determination of cyproterone acetate in plasma using restricted access material for sample pretreatment. Fully automated method for the liquid chromatographic determination of cyproterone acetate in plasma using restricted access material for sample pretreatment. J Chromatogr B 795:73-82 (Pubitemid 37289427)
20. Laban A, Markovic S, Stankov M, Djurdjevic P (2004) Simultaneous determination of gestodene and ethinyl estradiol in contraceptive formulations by RP-HPLC. Anal Lett 37:273-282 (Pubitemid 38299044)
21. Caglayan MG, Palabiyik IM, Onur F (2010) Development and validation of spectrophotometric and high-performance column liquid chromatographic methods for the simultaneous determination of dienogest and estradiol valerate in pharmaceutical preparations. Development and validation of spectrophotometric and high-performance column liquid chromatographic methods for the simultaneous determination of dienogest and estradiol valerate in pharmaceutical preparations. J AOAC Int 93:862-868
22. Kook K, Gabelnick H, Duncan G (2002) Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception 66:73-76 (Pubitemid 34880209)
23. Díaz-Cruz MS, Lopez de Alda MJ, Lopez R, Barcelo D (2003) Determination of estrogenes and progesterones by mass spectrometric techniques (GC/MS, LC/MC and LC/MS/MS). J Mass Spectrom 38:917-923 (Pubitemid 37121807)
24. Watson TG, Stewart BJ (1988) A sensitive direct radioimmunoassay for assessing D-norgestrel levels in human plasma. Ann Clin Biochem 25:280-287
25. Hieu DK, Reddersen G, Wehrberger K, Hobe G (1986) Radioimmunoassay of the progestagen dienogest using various methods of sample preparation of plasma. Pharmazie 41:711-714 (Pubitemid 17209234)
26. Zimmermann H, Maibauer R, Schütt B, Benda N, Kaufmann G, Pidun A (2001) Bioequivalence of dienogest as a single component and dienogest in combination with estradiol valerate after single administration to healthy postmenopausal women. Bioequivalence of dienogest as a single component and dienogest in combination with estradiol valerate after single administration to healthy postmenopausal women. Drugs Today 37(suppl G):75-86
27. Roumen FJME, Dieben TOM (2006) Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. Contraception 85:57-62
28. Nieuweboer B, Tack J, Täuber U, Hümpel M, Wendt H (1989) Development and application of a radioimmunoassay of the new progestagen gestodene. Contraception 40:313-323 (Pubitemid 19222985)
29. Nieuweboer B, Lübke K (1977) Radioimmunological determination of cyproterone acetate. Horm Res 8:210-218 (Pubitemid 8202644)
30. Wu Z, Zang C, Yang C, Zhang X, Wu E (2000) Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Analyst 125:2201-2205
31. Wang Q, Wu Z, Wang Y, Luo G, Wu E, Gao X, Li G (2001) Determination of levonorgestrel in human serum by liquid chromatographic-electrospray tandem mass spectrometry. Anal Lett 34:103-112 (Pubitemid 32198595)
32. Theron HB, Coetzee C, Sutherland FCW, Wiesner JL, Swart KJ (2004) Selective and sensitive liquid chromatography-tandem mass spectrometry method for the determination of levonorgestrel in human plasma. Selective and sensitive liquid chromatography-tandem mass spectrometry method for the determination of levonorgestrel in human plasma. J Chromatogr B 813:311-336
33. Licea-Perez H, Wang S, Bowen CL, Yang E (2007) A semiautomated 96-well plate method for the simultaneous determination of oral contraceptives in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry. A semiautomated 96-well plate method for the simultaneous determination of oral contraceptives in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B 852:69-76 (Pubitemid 46839209)
34. Zhao LZ, Zhong GP, Bi HC, Ding L, Deng Y, Guan S, Chen X, Huang ZY, Huang M (2008) Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers. Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers. Biomed Chromatogr 22:519-526 (Pubitemid 351722151)
35. Liu F, Xu Y, Liu A, Xu F, Hu W, Guo Q (2008) LC-tandem-MS validation for quantitative analysis of levonorgestrel in human plasma. Chromatographia 68:707-712
36. Moser C, Gschließer A, Mattle V, Wildt L, Griesmacher A, Seger C (2011) An ultra-sensitive online SPE-LC-MS/MS method for the quantification of levonorgestrel released from intrauterine devices. Anal Bioanal Chem 400:2655-2662
37. Bhaumik U, Ghosh A, Mandal U, Chatterjee B, Sarkar AK, Bose A, Ray KK, Pal TK (2008) Determination of drospirenone in human plasma by LC-tandem-MS. Chromatographia 68:713-720
38. Chambers EE, Diehl DM (2008) A highly selective method for the analysis of drospirenone in human plasma. Application note http://chromatographyonline. findanalytichem.com/lcgc/article/articleDetail. jsp?id0547965. Accessed 2011-09-07.
39. Liu XF, Ding CG, Ge QH, Zhou Z, Zhi XJ (2010) Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization. Yao Xue Xue Bao 45:87-92
40. Abib Junior E, Duarte LF, Vanunci MLP, Teixeira ML (2010) Bioequivalence of two oral contraceptive drugs containing ethinylestradiol and gestodene in healthy female volunteers. J Bioequiv Availab 2:125-130
41. Christiaens B, Fillet M, Chiap P, Rbeida O, Ceccato A, Streel B, De Graeve J, Crommen J, Hubert P (2004) Fully automated method for the liquid chromatographic-tandem mass spectrometric determination of cyproterone acetate in human plasma using restricted access material for on-line sample clean-up. Fully automated method for the liquid chromatographic-tandem mass spectrometric determination of cyproterone acetate in human plasma using restricted access material for on-line sample clean-up. J Chromatogr A 1056:105-110
42. Pereira AS, Mendes GD, Oliveira LSOB, Valle HF, De Nucci G (2005) Atmospheric pressure photoionization applied to quantitation of cyproterone acetate in human plasma. J Chromatogr Sci 43:513-517 (Pubitemid 41803335)
43. Wong FA, Edom RW, Duda M, Tischio JP, Huang M, Juzwin S, Tegegne G (1999) Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection. Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection. J Chromatogr B 734:247-255
44. Yang Y, Shao B, Zhang J, Wu Y, Duan H (2009) Determination of the residues of 50 anabolic hormones in muscle, milk and liver by very-high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry. Determination of the residues of 50 anabolic hormones in muscle, milk and liver by very-high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B 877:489-496
45. Lomus M, Kender T (2007) Determination of gestagens in kidney fat by liquid chromatography tandem mass spectrometry. Anal Chim Acta 586:233-238 (Pubitemid 46240031)
46. Xiong Z, Sun X, Huo T, Li N, Zheng Y, Sun Y (2010) Development and validation of UPLC-MS/MS method for simultaneous determination of gestodene and ethinyl estradiol in rat plasma. Biomed Chromatogr 24:160-168
47. Vulliet E, Wiest L, Baudot R, Grenier-Loustalot MF (2008) Multiresidue analysis of steroids at sub-ng/L levels in surface and ground-waters using liquid chromatography coupled to tandem mass spectrometry. Multiresidue analysis of steroids at sub-ng/L levels in surface and ground-waters using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr A 1210:84-91
48. Matejicek D, Kuban V (2007) High performance liquid chromatography/ion- trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel. High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel. Anal Chim Acta 588:304-315
49. Sun L, Yong W, Chu X, Lin JM (2009) Simultaneous determination of 15 steroidal oral contraceptives in water using solid-phase disk extraction followed by high performance liquid chromatographytandem mass spectrometry. Simultaneous determination of 15 steroidal oral contraceptives in water using solid-phase disk extraction followed by high performance liquid chromatographytandem mass spectrometry. J Chromatogr A 1216:5416-5423
50. Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL (2009) A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 4:526-534
51. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). http://www.fda. gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf. Accessed 2011-09-03.
52. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019-3030 (Pubitemid 36830428)
53. Delatour T, Mottier P, Gremaud E (2007) Limits of suspicion, recognition and confirmation as concepts that account for the confirmation transitions at the detection limit for quantification by liquid chromatography-tandem mass spectrometry. Limits of suspicion, recognition and confirmation as concepts that account for the confirmation transitions at the detection limit for quantification by liquid chromatography-tandem mass spectrometry. J Chromatogr B 1169:103-110